394 related articles for article (PubMed ID: 24614140)
1. Diagnosis and management of lymphomas and other cancers in HIV-infected patients.
Carbone A; Vaccher E; Gloghini A; Pantanowitz L; Abayomi A; de Paoli P; Franceschi S
Nat Rev Clin Oncol; 2014 Apr; 11(4):223-38. PubMed ID: 24614140
[TBL] [Abstract][Full Text] [Related]
2. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
Re A; Cattaneo C; Michieli M; Casari S; Spina M; Rupolo M; Allione B; Nosari A; Schiantarelli C; Vigano M; Izzi I; Ferremi P; Lanfranchi A; Mazzuccato M; Carosi G; Tirelli U; Rossi G
J Clin Oncol; 2003 Dec; 21(23):4423-7. PubMed ID: 14581441
[TBL] [Abstract][Full Text] [Related]
3. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy.
Castelli R; Schiavon R; Preti C; Ferraris L
Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049
[TBL] [Abstract][Full Text] [Related]
4. Hematologic cancers in individuals infected by HIV.
Carbone A; Vaccher E; Gloghini A
Blood; 2022 Feb; 139(7):995-1012. PubMed ID: 34469512
[TBL] [Abstract][Full Text] [Related]
5. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
6. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
[TBL] [Abstract][Full Text] [Related]
7. Raising awareness of non-Hodgkin lymphoma in HIV-infected adolescents: report of 2 cases in the HAART era.
Zangari P; Santilli V; Cotugno N; Manno E; Palumbo G; Lombardi A; De Vito R; Tchidjou H; Baldassari S; Ariganello P; Pontrelli G; De Florio F; Palma P; Bernardi S
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e134-7. PubMed ID: 23426000
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
10. Stem cell transplantation for lymphoma patients with HIV infection.
Michieli M; Mazzucato M; Tirelli U; De Paoli P
Cell Transplant; 2011; 20(3):351-70. PubMed ID: 20875226
[TBL] [Abstract][Full Text] [Related]
11. Optimizing treatment of HIV-associated lymphoma.
Noy A
Blood; 2019 Oct; 134(17):1385-1394. PubMed ID: 30992269
[TBL] [Abstract][Full Text] [Related]
12. Malignant lymphoma in the HIV-positive patient.
Meister A; Hentrich M; Wyen C; Hübel K
Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.
Tirelli U; Spina M; Gaidano G; Vaccher E; Franceschi S; Carbone A
AIDS; 2000 Aug; 14(12):1675-88. PubMed ID: 10985303
[No Abstract] [Full Text] [Related]
14. Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.
Pratesi C; Simonelli C; Zanussi S; Talamini R; Bortolin MT; Tedeschi R; Marus A; Caffau C; Michieli M; Tirelli U; De Paoli P
Clin Exp Immunol; 2008 Jan; 151(1):101-9. PubMed ID: 17931391
[TBL] [Abstract][Full Text] [Related]
15. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
Cingolani A; Fratino L; Scoppettuolo G; Antinori A
J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
[TBL] [Abstract][Full Text] [Related]
16. Immune reconstitution in HIV infection and its relationship to cancer.
Robertson P; Scadden DT
Hematol Oncol Clin North Am; 2003 Jun; 17(3):703-16, vi. PubMed ID: 12852652
[TBL] [Abstract][Full Text] [Related]
17. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus associated lymphoma.
Sparano JA
Curr Opin Oncol; 2003 Sep; 15(5):372-8. PubMed ID: 12960519
[TBL] [Abstract][Full Text] [Related]
19. γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation.
Pratesi C; Zanussi S; Tedeschi R; Bortolin MT; Talamini R; Rupolo M; Scaini C; Basaglia G; Di Maso M; Mazzucato M; Zanet E; Tirelli U; Michieli M; Carbone A; De Paoli P
PLoS One; 2015; 10(2):e0116887. PubMed ID: 25668032
[TBL] [Abstract][Full Text] [Related]
20. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
